Platelet-derived growth factor (PDGF) is one family of growth factors that regulate cell growth and differentiation. Rat Leydig cells express PDGF-β receptor (PDGFRB) during pubertal development. However, the mechanism of PDGF in the regulation of Leydig cell development is unclear. In the present study, rat immature Leydig cells were isolated from the testes of 35-day-old Sprague-Dawley rats and treated with 1 and 10 ng/mL of PDGF-BB. After 24 h of treatment, these cells were harvested for genomics profiling and the medium steroids were measured. 1 and 10 ng/mL PDGF-BB significantly increased androgen production by rat immature Leydig cells. Genomics profiling analysis showed that the expression levels of steroidogenic acute regulatory protein (Star) were increased by 2-fold. Further analysis showed that Fos expression level was increased 2-and 5-fold by 1 and 10 ng/mL PDGF-BB, respectively. In conclusion, PDGF-BB stimulated the differentiation of rat immature Leydig cells via regulating Star.
Introduction
Testosterone stimulates fertility and maintains the secondary sexual characteristics of males at adulthood (Ye et al. 2017) . The primary source of this hormone in males is the Leydig cell, which is located in the interstitial area of a mammalian testis. Pituitarysecreted luteinizing hormone (LH) and its receptor (LHCGR), cholesterol transportation into the Leydig cell via high-density lipoprotein receptor (SCARB1) and into the mitochondrion via steroidogenic acute regulatory protein (STAR) and androgen-biosynthetic enzymes, including P450 cholesterol side chain cleavage enzyme (CYP11A1), 3β-hydroxysteroid dehydrogenase 1 (HSD3B1), 17α-hydroxylase/17,20-lyase (CYP17A1) and 17β-hydroxysteroid dehydrogenase 3 (HSD17B3), are very critical for the production of testosterone in Leydig cells (Ge & Hardy 2007) . biomarker, LHCGR, SCARB1, STAR, CYP11A1, HSD3B1 and CYP17A1. The progenitor Leydig cell also has the high level of androgen-metabolizing enzyme 5α-reductase 1 (SRD5A1, gene Srd5a1) (Ge & Hardy 1998 , Feng et al. 2016 ) and 3α-hydroxysteroid dehydrogenase (AKR1C9 gene Akr1c9) (Ge & Hardy 1998) . However, the progenitor Leydig cell lacks the final-step androgen-biosynthetic enzyme (HSD17B3) for testosterone biosynthesis. Thus, the androstenedione formed after the enzyme catalysis of CYP11A1, HSD3B1 and CYP17A1 is metabolized into 5α-androstanedione by SRD5A1 and further by AKR1C9 into androsterone, which is secreted into the circulation (Ge & Hardy 1998) . The progenitor Leydig cell has the high proliferative capacity too, amplifying the Leydig cell number (Ge & Hardy 1997) . Around puberty (age, 35 days) in the rat, the progenitor Leydig cell transits into the immature Leydig cell, which is ovoid in shape and contains abundant lipid droplets. The immature Leydig cell has well-developed androgen-biosynthetic enzymes, including HSD17B3, but also has high levels of SRD5A1 and ARK1C9, and therefore, the formation of testosterone by HSD17B3 is metabolized into dihydrotestosterone by SRD5A1 and further into androstanediol (DIOL) by AKR1C9 (Ge & Hardy 1998) . The immature Leydig cell has the intermediate proliferative capacity (Ge & Hardy 1997) and can divide once (Hardy et al. 1989) . The immature Leydig cell matures into the adult Leydig cell around adult stages (56 day old). The adult Leydig cell is round in shape and produces mainly testosterone because the androgenmetabolizing enzyme SRD5A1 in adult Leydig cells is silenced around postnatal day 56 (Ge & Hardy 1998) .
Many factors have been reported to regulate the proliferation and differentiation of Leydig cells, including LH, growth factors, cytokines and steroids (see review Chen et al. 2009 , Ye et al. 2017 . One family of growth factors is platelet-derived growth factors (PDGFs). PDGFs are disulfide-linked homodimeric proteins. The family of growth factors has been reported to regulate cell proliferation, tissue remodeling, differentiation and growth (Basciani et al. 2010) .
Members of the PDGF family have been shown to be involved in the development of Leydig cells. PDGF-A and PDGF-B are expressed in the rat testis, forming homodimers of PDGF-AA and PDGF-BB as well as a heterodimer PDGF-AB (Betsholtz et al. 2001) . In fetal, neonatal and pubertal rat testis, PDGF-A and PDGF-B were found to be present in Sertoli cells (Gnessi et al. 1995 , Li et al. 1997 , Uzumcu et al. 2002 , and in adult rat testis, these two factors were found to be expressed in both Sertoli and Leydig cells (Gnessi et al. 1992) . There are at least two PDGF receptors that respond to PDGF stimulation. The PDGF homodimers bind to their corresponding tyrosine kinase receptors, PDGF receptor α (PDGFRA) and PDGF receptor β (PDGFRB), and the PDGF-AB heterodimer binds to both PDGFRA and PDGFRB, thereby activating the unique downstream pathways (Betsholtz et al. 2001) .
Both PDGF-A/PDGFRA and PDGF-B/PDGFRB are essential for the development of Leydig cells (Schmahl et al. 2008) . Adult Leydig cells did not differentiate in the adult knockout mice, which lacked expression of the Pdgfa (Gnessi et al. 1995) . Knockout of Pdgfra gene led to few Leydig cells in fetal mouse testis (Brennan et al. 2003) . Leydig cell conditional l knockout of Pdgfra or Pdgfrb also led to a significant reduction of Leydig cell number in the fetal testis (Schmahl et al. 2008) . However, the role of PDGF-BB in the pubertal development of Leydig cells is still not clear. Our objective of the present study was to analyze the possible regulatory effects of PDGF-BB on the Leydig cell lineage. To do so, we isolated rat immature Leydig cells and treated them with PDGF-BB in vitro. We identified a series of downstreamed genes that were regulated by PDGF-BB. 
Leydig cell isolation
Immature Leydig cells were purified as previously described (Ge & Hardy 1998) . Immature Leydig cells were used because they have been reported to express PDGFRB, and they have all testosterone biosynthetic and metabolizing enzymes (Ge & Hardy 1998) . In brief, the removed testis was perfused with a collagenase solution via the testicular artery and digested with the M-199 medium containing collagenase and DNase (Sigma-Aldrich) for 15 min. Then, the suspension was filtered through 100 µm 2-layer nylon mesh and the cells were separated under a Percoll gradient (Sigma-Aldrich). The cells with a density of 1.07-1.088 g/mL were collected and washed. Purified cells were evaluated by histochemical staining for HSD3B1 activity, with 0.4 mM etiocholanolone as the steroid substrate and NAD + as a cofactor (Payne et al. 1980) . The purity of immature Leydig cells was ≥95%.
Immature Leydig cell culture
To test the effects of PDGF-BB on androgen biosynthesis, isolated immature Leydig cells were seeded at each well of a 12-well plate. Cells were cultured in the presence of different concentrations of PDGF-BB (0, 1 or 10 ng/mL) alone or plus LH (10 ng/mL) or 22R-hydroxycholesterol (22R, 2 µM) in 1:1 DMEM:F-12 culture medium containing 0.1% bovine serum albumin in 5% O 2 and 34°C for 24 h, and this culture system causes very low oxidative stress of Leydig cells (Weissman et al. 2005) . 22R was used because immature Leydig cells are permeable to 22R, which was served as the substrate of CYP11A1 to judge its enzyme activity (Ge & Hardy 1998) . 1 or 10 ng/mL PDGF-BB were added to immature Leydig cells, and the cells were cultured for 24 h. After that, the media were collected for analysis of androgen. In another set of experiment, PDGF-BB (10 ng/mL) and its inhibitor PKI (20 nM) were used alone or in combination. 20 nM PKI was used because it had selective inhibition for PDGFRB (IC 50 = 4.2 nM) over PDGFRA (IC 50 = 45 nM) (Ho et al. 2005) . Medium testosterone and androstanediol from 24-h culture media were measured, and then the levels after treatment were compared with the control (no treatment, basal).
Thymidine incorporation
Immature Leydig cells were labeled with [ 3 H]thymidine (DuPont-New England Nuclear, Boston, MA, USA) at 1 Ci/mL (specific activity 104.7 Ci/mmol) during the last 2 h of incubation as described (Ge & Hardy 1997) . After labeling, the Leydig cells were washed twice with PBS and harvested by centrifugation at 750 g. Leydig cells were lysed in 0.5 mL hyamine hydroxide (ICN Radiochemicals, Irvine, CA, USA), and radioactivity was measured in a liquid scintillation counter (PerkinElmer).
RNA extraction
Total RNAs were extracted from immature Leydig cells using the TRIzol Kit according to the manufacturer's instructions (Invitrogen). Briefly, rat immature Leydig cells were collected after treatment with PDGF-BB (0, 1 or 10 ng/mL) for 24 h and dissolved in TRIzol and homogenized in a glass homogenizer, and total RNAs were extracted. RNA pellets were eluted with 70% ethanol and air dried. Total RNAs were resuspended in the RNasefree water and purified using the RNeasy Kit (Qiagen) according to the manufacturer's instructions. The RNA concentration was determined using a NanoDrop 2000 spectrophotometer (Thermo Fisher Scientific) and the RNA integrity in individual RNA samples were analyzed with Agilent 2100 Bioanalyzer (Santa Clara, CA, USA).
Microarray hybridization and scanning
The RatRef-12 Expression BeadChip containing 21,910 rat genes was used. Genes are picked up from the NCBI RefSeq database to cover the whole rat transcriptome. Three groups of samples were used: 0, 1, and 10 ng/mL PDGF-BB-treated immature Leydig cells. Four replicates per group were performed. Probe labeling, hybridization, washing and scanning were performed using the Illumina Total Prep Kit (Applied Biosystems) as previously described (Griffin et al. 2010) . First strand of cDNA was synthesized in a total volume of 20 μL with the supplied reagents. The complete first strand product was used for the second strand synthesis, followed by column purification. The purified product was then used for in vitro transcription using T7 polymerase. Biotin-16-dUTP was incorporated and the biotinylated complementary RNA (cRNA) probe as prepared. The probe integrity was verified using the Agilent 2100 Bioanalyzer. Labeled cRNA (750 ng) was hybridized to the array chip overnight at 58°C in a total volume of 30 μL of hybridization buffer, followed by post-hybridization stringency washing. The chip was scanned in the NextSeq 550 System (Illumina).
Microarray data analysis
Microarray data analysis was performed as previously described . Briefly, after scanning, the microarray data were imported into the BeadStudio software (Illumina) for normalization, preliminary analysis and filtering. The background subtraction was performed, and the Illumina custom error model was used to generate present/absent calls for each probe ('present' defined as P < 0.01 for signal detection) and to call differentially expressed genes (defined as P < 0.05 after false discovery rate correction). For each array, all probe sets were normalized to a mean signal intensity value of 100. Normalized data from BeadStudio was filtered to exclude genes not expressed in the Leydig cells (i.e. data from probes that were classed as 'absent' in all samples). All of the 21,910 genes were present in the data based on which further analyses were carried out. The data were further imported into Microsoft Access 2010, and queries to find the increased and decreased genes after PDGF-BB treatment when compared to the control were generated to find the expression levels.
Biological pathway analysis
Biological pathway analysis was performed as previously described . The Gene MicroArray Pathway Profiler 2.1 (GenMAPP2.1, San Francisco, CA, USA) software was used to find the biological pathway, and GO pathway was generated according to the software developer's instruction. The GenMAPP2.1 was used to create a map of signal pathways for the potential pathways. We imported our statistical results into the program and illustrated biological pathways containing differentially expressed genes. The results of the differential gene expression profile were validated by RT-qPCR.
Quantitative real-time PCR (RT-qPCR)
Briefly, first-strand synthesis of DNA and RT-qPCR were performed as previously described (Lin et al. 2009 ). RT-qPCR was carried out in a 20 µL volume in a 96-well plate using the SYBR Green PCR Kit from Applied Biosystems. Primer titration was performed with the concentration of 300 nM. Fluorescence was detected using the ABI 7700 system (PE Applied Biosystems). Each sample was run in duplicate and in parallel with no template controls. The relative mRNA levels of targeted genes were adjusted to house-keeping gene, ribosomal protein S16 (Rps16), as the internal control. Rsp16 in Leydig cells has been used as the internal control in many studies because it showed consistent expression , Zhang et al. 2015 . Furthermore, in this microarray, the values for Rsp16 levels in 0, 1 and 10 ng/mL PDGF-BB groups were 40 ± 3, 50 ± 6, and 48 ± 4, respectively, and there were no significant changes between groups. The Ct value was read and the levels of the target mRNAs were calculated using the standard curve method as previously described 
Western blotting analysis
Immature Leydig cells after PDGF-BB treatment were homogenized and lysed. Protein concentrations in samples were measured using the Bio-Rad Protein Assay Kit (cat# 500-0006; Bio-Rad) according to manufacturer's protocol. Bovine serum albumin was used as the protein standard. Samples (50 µg protein) were boiled in equal volumes of sample loading buffer, containing 20% glycerol, 5% sodium dodecyl sulfate, 3.1% dithiothreitol and 0.001% bromophenol blue. Samples were electrophoresed on 10% polyacrylamide gels containing sodium dodecyl sulfate. Proteins were electrophoretically transferred onto nitrocellulose membrane. After one-hour exposure to 5% non-fat milk to block nonspecific binding, the membranes were incubated with the primary antibodies (1:1000 dilution) against LHCGR (Santa Cruz), CYP11A1 (Santa Cruz), CYP17A1 (Santa Cruz), STAR (Pterosaur Biotech, Hangzhou, Zhejiang, China) and actin β (ACTB, Cell Signaling Technology). The membranes were then washed and incubated with a 1:1000 dilution of antirabbit or anti-goat antiserum (R&D Systems) that was conjugated to horseradish peroxidase. The washing step was repeated, and immunoreactive bands were visualized by chemiluminescence using an ECL kit (Amersham). The density was scanned by ImageJ software.
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Medium testosterone and androstanediol measurement
The medium testosterone and androstanediol were fractionated using Sephadex LH-20 (Pharmacia Biotech, Uppsala, Sweden) column chromatography as previously described (Ge & Hardy 1998 ). The elution system was chloroform-butane-ethanol (50:50:1, v/v/v) saturated with distilled water. Clear separation of testosterone and androstanediol in this system was confirmed using radiolabeled steroids (Ge & Hardy 1998 ). The recovery rates following extraction and column separation were 75.6 ± 4.2% for testosterone and 87.1 ± 2.1% for DIOL, and these were used to correct the final concentration of testosterone and DIOL measured by RIA. Separated medium testosterone and androstanediol concentrations were measured with a tritium-based RIA as previously described (Cochran et al. 1981) . Inter-assay and intraassay variations of the androgen were 7-8%.
Statistics
All data are expressed as means ± s.e.m. Data were subjected to analysis by one-way ANOVA test followed by ad hoc Tukey multiple comparisons to identify significant differences between the tested group and the control.
Normalized signal values of microarray data were transformed to the log base 10, and an ANOVA analysis was performed. Differences were regarded as significant at P < 0.05.
Results
PDGF-BB stimulates androgen production in immature Leydig cells
Immature Leydig cells are the cells at the intermediate stage during pubertal development of Leydig cells (Ge & Hardy 1997 , 1998 , and they primarily produced androstanediol (Ge & Hardy 1998) . We investigated the effects of PDGF-BB on androgen production of rat immature Leydig cells. As shown in Fig. 1 , PDGF-BB stimulated basal production of testosterone (Fig. 1A) or androstanediol (Fig. 1B) or testosterone plus androstanediol at 10 ng/mL (Fig. 1C) . However, PDGF-BB did not affect the androgen production of rat immature Leydig cells under the stimulation of LH and 22R (Fig. 1D , E, F, G, H and I).
To dissect whether PDGF-BB exerts its action via PDGFRB, we used a PDGFRB inhibitor, PKI. 20 nM PKI was used because it selectively inhibited PDGFRB (IC 50 = 4.2 nM) over PDGFRA (IC 50 = 45 nM) (Ho et al. 2005) . PKI (20 nM) alone did not affect androgen production of immature Leydig cells. However, it reversed PDGF-BBstimulated testosterone ( Fig. 2A) , androstanediol (Fig. 2B ) Figure 1 Effects of PDGF-BB on basal, LH-and 22R-hydroxycholesterol (22R)-stimulated androgen production in rat immature Leydig cells. Immature Leydig cells were cultured without (basal) or with 10 ng/mL LH (LH-stimulated) or 2 µM 22R for 24 h. Panel A, B and C, basal condition; panel D, E and F, LH-stimulated condition; panel G, H and I, 22R-stimulated condition. Mean ± s.e.m., n = 8. *, **indicate significant difference at P < 0.05 and P < 0.01, respectively, when compared to the control (PDGF-BB, 0 ng/mL). and testosterone plus androstanediol (Fig. 2C) . This indicates that PDGF-BB exerts its action via PDGFRB.
PDGF-BB stimulates Leydig cell DNA synthesis
Previous studies showed that immature Leydig cells were capable of proliferating (Ge & Hardy 1997) . PDGF-BB is also a possible growth factor to stimulate cell proliferation (Odeh et al. 2014) . We measured immature Leydig cell DNA synthesis using 3 H-thymidine incorporation. As shown in Fig. 3 , PDGF-BB (10 ng/mL) stimulated thymidine incorporation. To dissect whether PDGF-BB exerts its action via PDGFRB, we treated the cells with PKI alone or together with PDGF-BB (10 ng/mL). PKI alone did not affect thymidine incorporation, but it reversed PDGF-BB-stimulated thymidine incorporation (Fig. 3) . This indicates that PDGF-BB exerts its proliferation-stimulating action via PDGFRB.
Microarray analysis reveals PDGF-BB-mediated Leydig cell steroidogenesis
We examined the effects of PDGF-BB on Leydig cell gene expression levels using microarray analysis of transcriptome. We analyzed a genome-wide expression containing 21,910 probes, of these probes, 9466 probes were detected in the control (2 fold about the noise background). Of 9466 probes, 10 ng/mL PDGF-BB treatment (1 ng/mL P1; 10 ng/mL, P10), or both (20 nM PKI + 10 ng PDGF-BB, PKI + P10) for 24 h. Mean ± s.e.m., n = 3. Identical letters between two groups indicate no significant difference at P < 0.05. upregulated 197 gene expression by ≥2 fold, in which 57 genes were also upregulated by 1 ng/mL PDGF-BB. Of the increased genes, we found that Star was significantly increased by 1.9-and 2.1-fold by 1 and 10 ng/mL PDGF-BB, respectively. 10 ng/mL PDGF-BB decreased 238 gene expression by ≥2 fold, in which 58 genes were also decreased by 1 ng/mL PDGF-BB. Of decreased genes, Akr1c9 and Amhr2, which are biomarkers in the earlier stage of Leydig cells and significantly reduced during the maturation of immature Leydig cells were decreased by ≥2 fold.
RT-qPCR verification
To validate microarray gene analysis, we used RT-qPCR verified the gene expression levels and specifically examined the effects of PDGF-BB on the expression levels of steroidogenesis-related and proliferation-related genes in rat immature Leydig cells, including Lhcgr, Scarb1, Star, Cyp11a1, Hsd3b1, Cyp17a1, Hsd17b3, Srd5a1, Akr1c9 and Sult1a1 in different sets of samples. We also analyzed Leydig cell maturation biomarker Insl3 and cell proliferation biomarker Ccnd1. As shown in Fig. 4 , PDGF-BB upregulated Star, Hsd17b3 and Insl3 expression levels at ≥1 ng/mL. At 1 ng/mL PDGF-BB also increased expression of Cyp11a1 and Srd5a1, but it did not increase their expression levels at 10 ng/mL. PDGF-BB at the higher concentration (10 ng/mL) significantly increased Ccnd1 expression level. PDGF-BB concentration-dependently decreased the expression levels of Akr1c9 and Sult1a1 but did not affect Scarb1, Hsd3b1 and Cyp17a1 expression levels. These data were in agreement with the changes of these genes in the microarray dataset. For example, in RT-qPCR data, 1 and 10 ng/kg PDGF-BB increased expression of Star by 2.78-and 2.45-fold, respectively while in microarray data they did by 1.9-and 2.1-fold, respectively. In RT-qPCR data, 1 and 10 ng/kg PDGF-BB decreased the expression of Akr1c9 by 4-and 7.7-fold, respectively while in microarray data they did by 2-and 6-fold, respectively. These data indicate that PDGF-BB specifically regulates some gene expression levels.
Figure 4
Effects of PDGF-BB on gene expression levels in rat immature Leydig cells. Immature Leydig cells were cultured in the basal condition with PDGF-BB (1 and 10 ng/mL) for 24 h. Three sets of genes were selected: genes with increased expression (Star, Hsd17b3, Insl3, Cyp11a1, Srd5a1, and Ccnd1) , and genes with reduced expression (Akr1c9, Sult1a1, and Lhcgr) as well as unchanged genes (Scarb1, Hsd3b1, and Cyp17a1). Mean ± s.e.m., n = 4. *, **, ***indicate significant difference at P < 0.05, P < 0.01, and P < 0.001, respectively, when compared to the control (PDGF-BB, 0 ng/mL).
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Effects of PDGF-BB on Leydig cell proteins
We examined some specific protein (LHCGR, STAR and HSD17B3) levels in Leydig cells after PDGF-BB treatment (Fig. 5) . We found that STAR (P < 0.001) and HSD17B3 (P < 0.05) levels were significantly increased by 8.4-fold and 2.9-fold, respectively, at ≥1 ng/mL PDGF-BB, and LHCGR level was significantly decreased by 2-fold at 10 ng/mL PDGF-BB (P < 0.05). This was in agreement with the trend of their mRNA levels (e.g., Lhcgr was decreased by 2.4 fold by 10 ng/mL PDGF-BB).
Major pathways of PDGF-BB
We presented the genes with ≥4-fold alteration in Table 1 (increased expression of genes) and Table 2 (decreased expression of genes). These genes were listed according to the GO analysis for biological pathway by Gene MicroArray Pathway Profiler 2.1. The increased expression of genes include cell structure proteins (Myo1b, Sgcg, Add2), extracellular matrix proteins (Lsamp, Col8a1, Mmp3, Igsf4c) , growth factors and their receptors (Npy1r, Il1rl1, Igfbp3, Ucn2, Ednrb, Adora2b, Fst, Inhba, Gal, Gap43, Npw) , intracellular signaling proteins (Phlda1, Wisp1, Serpinb2, Arhgdig, Rgs4, Egr1, Dusp6, Serinc2, Egr2, Ier2, Sh2b2, Dclk2), Usp13, Cyp24a1, Akr1c18, Cpe, Rrm2, Enpp1, Ptgis, Serpine1, Mthfd1l, Car2) , transcription factors (Maf, Runx1, Etv4, Hmga1, Fos) , transporters (Slc17a1, Slc1a5, A2m). The decreased genes include cell structure proteins (LOC287167, Eln), growth factors and their receptors (Lgals5, Ccl20, Cfb, Cxcl11, Cxcl10, Cxcr7, Amhr2, Ccl12, Ccl11, Il18bp) , intracellular signaling proteins (Pla2g2a, Ifit1, Ifit3, Tnnt2, Ubd, Omd, Gzmb, Defb52, Gbp5, Mx2, Mx1, Rgnef, Slfn3) , metabolismrelated proteins (Akr1cl1, Akr1c9, Oas1a, Maob, Enpp2, Sult1a1, Cyp4f4) .
Using GenMAPP2, we discovered several pathways that were specific to the regulation of PDGF-BB. As shown in Fig. 6 for steroidogenesis pathway, the expression level of Star was significantly increased and the expression levels of Akr1c9 and Sult1a1 were significantly decreased. The expression levels of other steroidogenic enzymes were not changed (Supplementary Table 2 ).
The expression levels of cholesterol biosynthesis pathway (Hmgcs1, Idil, Fdps, Sqle, Cyp51, Sc4mol, and Dhcr7) were decreased by 2-4 fold (Fig. 7) . This indicates that after PDGF-BB treatment the de novo cholesterol biosynthesis is reduced.
Discussion
In the present study, we found that PDGF-BB positively regulated androgen production of rat immature Leydig cells by increasing the expression of Star and Hsd17b3, and decreasing the expression of Akr1c9 and Sult1a1. This finding is novel.
Previous studies demonstrated that all cells in the Leydig cell lineage had PDGFRB (Ge et al. 2006 , Figure 5 Effects of PDGF-BB on protein expression levels in rat immature Leydig cells. Immature Leydig cells were cultured in the basal condition with PDGF-BB (1, 10 ng/mL) for 24 h. LHCGR, STAR, and HSD17B3 protein levels were measured by Western blot. Panel A, Western blot images; panel B, C and D, quantitative data. Mean ± s.e.m., n = 4. *, ***indicate significant difference at P < 0.05 and P < 0.001, respectively, when compared to the control (PDGF-BB, 0 ng/mL).
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Gene symbol Gene name PDGF-BB (ng/mL) 0 1 10
Structure protein Myo1b Myosin Ib 9 ± 1 14 ± 3 (2) 47 ± 4 (5)* Sgcg Sarcoglycan gamma 7 ± 2 14 ± 2 (2) 33 ± 2 (5)* Add2
Adducin 2 7 ± 1 12 ± 3 (2) 26 ± 3 (4)* Extracellular matrix Lsamp Limbic system-associated membrane protein 4 ± 2 14 ± 1 (3) 40 ± 7 (10)* Col8a1
Procollagen type VIII α1 12 ± 4 31 ± 6 (3) 96 ± 6 (8)* Mmp3
Matrix metallopeptidase 3 996 ± 63 1625 ± 38 (2) 5046 ± 69 (5)* Igsf4c
Immunoglobulin superfamily, member 4C 29 ± 2 34 ± 1 (1) 127 ± 6 (4)* Growth factors and receptors Npy1r Neuropeptide Y receptor Y1 1 ± 2 4 ± 3 (4) 50 ± 6 (50)* Il1rl1
Interleukin 1 receptor-like 1 47 ± 12 190 ± 16 (4) 557 ± 18 (12)* Igfbp3
Insulin-like growth factor binding protein 3 188 ± 29 310 ± 8 (2) 1104 ± 25 (7)* Ucn2
Urocortin 2 5 ± 4 17 ± 2 (3) 37 ± 3 (7)* Ednrb Endothelin receptor type B 301 ± 5 588 ± 18 (2) 1539 ± 34 (5)* Adora2b
Adenosine A2B receptor 21 ± 2 40 ± 5 (2) 73 ± 3 (4)* Fst Follistatin 37 ± 11 31 ± 4 (1) 148 ± 7 (4)* Inhba
Inhibin beta-A 14 ± 2 23 ± 2 (2) 57 ± 1 (4)* Gal Galanin 22 ± 3 37 ± 3 (2) 89 ± 3 (4)* Gap43
Growth associated protein 43 69 ± 2 96 ± 1 (1) 274 ± 7 (4)* Npw
Neuropeptide W 39 ± 3 46 ± 2 (1) 142 ± 4 (4)* Intracellular signaling Phlda1 Pleckstrin homology-like domain family A1 3 ± 1 7 ± 2 (2) 39 ± 2 (15)* Wisp1 WNT1 inducible signaling pathway protein 1 5 ± 2 12 ± 2 (2) 84 ± 2 (15)* Serpinb2 serine peptidase inhibitor, clade B, member 2 43 ± 4 66 ± 5 (2) 314 ± 8 (7)* Arhgdig Rho GDP dissociation inhibitor (GDI) gamma 20 ± 1 49 ± 2 (2) 141 ± 5 (7)* Rgs4
Regulator of G-protein signaling 4 43 ± 12 97 ± 5 (2) 267 ± 20 (6)* Egr1
Early growth response 1 475 ± 27 737 ± 33 (2) 2859 ± 60 (6)* Dusp6
Dual specificity phosphatase 6 111 ± 2 126 ± 3 (1) 614 ± 20 (6)* Serinc2
Serine incorporator 2 117 ± 12 214 ± 6 (2) 557 ± 15 (5)* Egr2
Early growth response 2 317 ± 29 301 ± 7 (1) 1466 ± 33 (5)* Ier2
Immediate early response 2 297 ± 17 442 ± 11 (2) 1202 ± 17 (4)* Sh2b2 SH2B adaptor protein 2 34 ± 1 78 ± 4 (2) 133 ± 4 (4)* Dclk2 Doublecortin-like kinase 2 18 ± 4 44 ± 2 (2) 67 ± 4 (4)* Metabolism Upp1
Uridine phosphorylase 1 764 ± 64 1430 ± 26 (2) 4332 ± 131 (6)* Usp13
Ubiquitin specific protease 13 9 ± 1 38 ± 4 (4) 50 ± 2 (5) Cyp24a1
Cytochrome P450, subfamily 24 8 ± 2 18 ± 3 (2) 44 ± 3 (5)* Akr1c18
Aldo-keto reductase family 1, member C18 9 ± 1 25 ± 2 (3) 44 ± 1 (5)* Cpe Carboxypeptidase E 12 ± 2 34 ± 5 (3) 52 ± 4 (4) Rrm2
Ribonucleotide reductase M2 168 ± 11 289 ± 10 (2) 640 ± 38 (4)* Enpp1
Phosphodiesterase 1 532 ± 121 1324 ± 48 (2) 2000 ± 37 (4)* Ptgis Prostaglandin I2 525 ± 68 1133 ± 88 (2) 2170 ± 72 (4)* Serpine1
Serine peptidase inhibitor, clade E, member 1 323 ± 28 504 ± 12 (2) 1195 ± 25 (4)* Mthfd1l
Methylenetetrahydrofolate dehydrogenase 1 46 ± 11 107 ± 4 (2) 165 ± 4 (4)* Car2
Carbonic anhydrase II 156 ± 2 200 ± 7 (1) 550 ± 1 (4)* Transcription factors Maf Monocyte to macrophage differentiation 117 ± 7 213 ± 6 (2) 810 ± 16 (7)* Runx1
Runt related transcription factor 1 85 ± 10 202 ± 17 (2) 511 ± 10 (6)* Etv4 PREDICTED: ets variant gene 4 6 ± 2 8 ± 1 (1) 35 ± 5 (5)* Hmga1
High mobility group AT-hook 1 23 ± 6 43 ± 2 (2) 117 ± 1 (5)* Fos FBJ murine osteosarcoma viral oncogene 66 ± 1 102 ± 3 (2) 315 ± 17 (5)* Boll Bol, boule-like 54 ± 8 102 ± 2 (2) 191 ± 10 (4)* Transporters Slc17a1 Solute carrier family 17 12 ± 2 21 ± 3 (2) 56 ± 1 (5)* Slc1a5
Solute carrier family 1 128 ± 10 196 ± 6 (2) 504 ± 23 (4)* A2m
Alpha-2-macroglobulin 19 ± 3 32 ± 2 (2) 70 ± 1 (4)* Unknown proteins RGD1560268 Similar to AT motif-binding factor 4 ± 2 19 ± 2 (6) 25 ± 1 (7)* RGD1562464 Similar to hypothetical protein A030011M19 6 ± 2 6 ± 2 (1) 31 ± 1 (5)* LOC498829 PREDICTED: Ab2-143 262 ± 92 718 ± 38 (3) 1038 ± 38 (4)* RGD1562920 PREDICTED: similar to Aig1 protein 163 ± 12 252 ± 7 (2) 596 ± 7 (4)* RGD1564216 PREDICTED: similar to Myoferlin 41 ± 4 64 ± 6 (2) 152 ± 3 (4)* RGD1305534 PREDICTED: similar to C21ORF5 17 ± 2 33 ± 4 (2) 64 ± 3 (4)* () Fold changes compared to 0 ng/PDGF-BB. *Indicates significant difference between 1 and 10 ng/mL PDGF-BB groups at P < 0.05.
of Star and androgen-biosynthetic enzymes (Cyp11a1, Hsd3b1, Cyp17a1, and Hsd17b3) are increased while the androgen-metabolizing enzymes (Srd5a1, Akr1c9, Sult1a1) are decreased (Ge & Hardy 1998 , Zhang et al. 2013 . Indeed, we found that after 24 h of treatment PDGF-BB concentration-dependently increased the expression levels of Star and Hsd17b3 while decreased that of Akr1c9 and Sult1a1 (Fig. 6 and Tables 1 and 2 ). The Star mRNA (Fig. 4) and STAR protein (Fig. 5 ) levels were remarkably increased. STAR mediates the ratelimiting step in the androgen biosynthesis in the Leydig cells, in which it serves the carrier to transport cholesterol, the substrate for steroidogenesis, from the Leydig cell mitochondrial outer membrane into the inner membrane , Lemaire et al. 2006 , where CYP11A1 cleaves the cholesterol side chain to form pregnenolone. There are many results to point to the crucial role of STAR in regulating steroidogenesis (reviewed in Thomas et al. 1988) . Many signaling pathways, including protein kinase A (PKA), protein kinase C, and nuclear receptor, are involved in the regulation of transcription of Star gene (reviewed in De Jong et al. 2002) . The Star gene is transcriptionally regulated via the concerted action of multiple proteins that bind directly or indirectly to the DNA regulatory elements (Manna et al. 2003 (Manna et al. , 2004a Transcriptional activation by cAMP signaling after LH-stimulation is mediated through the interaction of the cAMP-response element (CRE)-binding protein (CREB) with CRE-like elements including an overlapping CRE2/AP-1 motif (Fos/Jun) in the Star gene promoter because the promoter lacks the classic conserved CRE (TGACGTCA) (Manna et al. 2003 (Manna et al. , 2004a . The CREB/ activating transcription factor (ATF) and Fos/Jun interact with themselves or each other to form selective dimers Figure 6 Steroidogenesis pathway in at immature Leydig cells after PDGF-BB treatment. Star level was significantly increased by 2 fold. Akr1c9 and Sult1a1 levels were significantly decreased by 2-fold. PDGF0, PDGF1 and PDGF10 represent the doses of 0, 1 and 10 ng/mL. that bind to closely related CRE and AP-1 sequences and induce transcriptional responses. CREB binds to DNA as a homodimer and it is activated after phosphorylation at Ser133 of CREB by several kinases including PKA (Clem et al. 2005) . Fos members bind to DNA as heterodimers with Jun proteins (Wagner 2001) . Expression of Fos is regulated by many extracellular signal factors. FOS has been demonstrated to bind to the CRE2/AP-1 motif alone transactivating basal Star gene transcription. In the present study, we demonstrated that Fos expression level was increased 2 fold and 5 fold by 1 and 10 ng/mL PDGF-BB, respectively (Table 1) . This suggests that PDGF-BB increases Star expression via increasing the Fos expression. Interestingly, when PDGF-BB together with LH treatment was performed, androgen production was not changed. The exact mechanism is not unclear. We speculated that LH already maximally increased androgen production, which was 5 fold compared to the basal level and this may mask the stimulatory effects of PDGF-BB.
We also found that the significant decrease of Akr1c9 even at 1 ng/mL PDGF-BB. Akr1c9 encodes AKR1C9 (3α-hydroxysteroid dehydrogenase), which catalyzes the metabolism of dihydrotestosterone, a potent androgen, into androstanediol, a weak androgen. The expression level of Akr1c9 is the highest in the progenitor Leydig cells and gradually declines and reaches the lowest level in adult Leydig cells (Shan et al. 1995 , Ge & Hardy 1998 . This indicates that PDGF-BB promotes the development of immature Leydig cells. The regulation of Akr1c9 expression is far from clear in Leydig cells. A previous study demonstrated that both LH and androgen can increase Akr1c9 expression (Shan et al. 1995) . Interestingly, liver Akr1c9 gene promote region contains AP-1 site (Lin & Penning 1995) , whether FOS can regulate via this 
Journal of Molecular Endocrinology site awaits for a further investigation in the future. In our study, we also found that Sult1a1 was significantly reduced. SULT1A1 is an enzyme that catalyzes the sulfate conjugation of many steroid hormones, neurotransmitters, drugs, and xenobiotic compounds. At the higher concentration (10 ng/mL), PDGF-BB also stimulated the proliferation of rat immature Leydig cells as evidence of increased incorporation of thymidine into these cells (Fig. 3) . Interestingly, PDGF-BB is a potent stimulator of the mitosis of stem Leydig cells . In the present study, the Ccnd1 expression level was significantly increased by 10 ng/mL PDGF-BB, indicating that this growth factor can regulate the cell proliferation via increasing expression of CCND1. PDGF-BB has been reported to increase Ccnd1 expression in mesenchymal stem cells for their proliferation (Gharibi et al. 2012 ).
There are not many studies about the effects of PDGF-BB on steroidogenic cells. One study showed that PDGF-BB inhibited the activity of SRD5A1 and HSD3B1 in cultured Leydig cells from (immature Leydig cells) 25-dayold rat testis (Murono & Washburn 1990) , while another study showed it increased LH-stimulated T production in vitro (Loveland et al. 1993 , Risbridger 1993 . PDGF-BB also inhibited stem Leydig cell commitment into the Leydig cell lineage in rats by reducing testosterone production after the stem Leydig cells were cultured in the presence of LH and ITS (Odeh et al. 2014) . However, in the present study, we clearly demonstrated that PDGF-BB alone stimulated androgen production in rat immature Leydig cells (Fig. 1) . This indicates that the effects of PDGF-BB on Leydig cell development depending on the stages of Leydig cells. The pathway of PDGF-BB stimulated steroidogenesis is not clear until the present study, in which we demonstrated that it increased the expression levels of Star and Hsd17b3. PDGF-BB might have significant physiological action on Leydig cell development since Leydig cell conditional l knockout of Pdgfrb in mice led to a significant reduction of Leydig cell number in the fetal testis (Schmahl et al. 2008) . However, the exact concentration of PDGF-BB in the pubertal rat testis is still not known. Furthermore study is required to identify its physiological level.
In conclusion, the present study demonstrated that PDGF-BB regulated the steroidogenesis of immature Leydig cells by increasing the expression levels of Star and steroidogenic enzyme gene Hsd17b3.
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